Clinical High and Genomic Low Hormone Receptor-positive Early Breast Cancer Patients With or Without Adjuvant Chemotherapy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
A prospective, randomized, comparative study to evaluate efficacy of anticancer chemotherapy in predicting prognosis and determining chemotherapy method in early Hormone Receptor-positive breast cancer patients with clinicopathological high risk and GenesWell™ BCT low risk at multi-center in Korea
Epistemonikos ID: c332c46ffdd9f1b2896eb70aeca66b2afbc03b0d
First added on: May 07, 2024